-
Sector Analysis
Peanut Allergy: Opportunity Analysis and Forecasts to 2027
Peanut allergy is defined as a harmful health effect resulting from a specific and reproducible immune response following the ingestion of peanuts. While exposure to dietary antigens within the gastro-intestinal tract normally leads to oral tolerance, in certain individuals this mechanism fails. This results in sensitization and subsequent allergic responses towards innocuous food antigens. The most dangerous of these responses is an acute systemic reaction called anaphylaxis. Peanut allergy has prevalence of 1-2.5% in developed nations and a low rate...
-
Product Insights
Pollen Allergy Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pollen Allergy Global Clinical Trials Review, H1, 2018" provides an overview of Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Grass Pollen Allergy Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Grass Pollen Allergy Global Clinical Trials Review, H2, 2017" provides an overview of Grass Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Grass Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Birch Pollen Allergy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H1, 2017" provides an overview of Birch Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Birch Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Conjunctivitis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Conjunctivitis Global Clinical Trials Review, H1, 2017" provides an overview of Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hypersensitivity Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypersensitivity Global Clinical Trials Review, H2, 2017" provides an overview of Hypersensitivity clinical trials scenario. This report provides top line data relating to the clinical trials on Hypersensitivity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
House Dust Mite Allergy Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “House Dust Mite Allergy Global Clinical Trials Review, H2, 2017" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Conjunctivitis Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Conjunctivitis Global Clinical Trials Review, H1, 2019" provides an overview of Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Allergic Rhinitis Immunotherapy – Opportunity Analysis and Forecasts to 2028
Allergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous inhaled substance in the environment with one or more of the following symptoms: rhinorrhea, sneezing, nasal congestion, and pruritus of the eyes, nose, and palate. Based on epidemiological analysis by GlobalData, in 2018 there were over 70.5M 12-month diagnosed prevalent cases of AR among adults and adolescents throughout the seven major pharmaceutical markets (7MM) covered in this report, the US, 5EU (France,...
-
Product Insights
Birch Pollen Allergy Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Birch Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Birch Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...